Subjective memory complaints and medication adherence among hypertensive Korean older adults with multimorbidity: mediating effect of depression and social support
View abstract on PubMed
Summary
This summary is machine-generated.Subjective memory complaints in older adults are linked to lower medication adherence, with depression playing a mediating role. Interventions should address memory and depression to improve adherence in this population.
Area Of Science
- Gerontology
- Cognitive Science
- Public Health
Background
- Medication adherence (MA) is crucial for managing hypertension and preventing complications.
- Older adults may face challenges with MA due to cognitive decline, with subjective memory complaints (SMC) as potential early indicators.
- The interplay between SMC, MA, depression, and social support in older adults remains under-researched.
Purpose Of The Study
- To investigate the effect of subjective memory complaints (SMC) on medication adherence (MA) in community-dwelling hypertensive older adults.
- To examine the mediating roles of depression and social support in the relationship between SMC and MA.
Main Methods
- A descriptive cross-sectional study involving 195 hypertensive older adults with multimorbidity in South Korea.
- Data collected via face-to-face surveys from January to March 2018.
- Mediation analysis using PROCESS macro v4.2 to assess the influence of depression and social support on the SMC-MA relationship.
Main Results
- SMC positively correlated with depression; social support and MA showed negative correlations.
- Depression significantly mediated the relationship between SMC and MA.
- Social support did not significantly mediate the SMC-MA relationship, nor did the combined mediation of depression and social support.
Conclusions
- Healthcare for older adults with hypertension and multimorbidity necessitates a holistic assessment of factors impacting medication management.
- Interventions targeting memory enhancement and depression alleviation are recommended to improve medication adherence in this demographic.
Related Concept Videos
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

